Haemostatix's Grant

Haemostatix raised a round of funding on November 05, 2010. Investors include Wellcome Trust.

Haemostatix is a biopharmaceutical company developing first-in-class therapies for the treatment of bleeding or 'haemostasis'. The company has pioneered a new approach to haemostasis based on targetin…

Articles about Haemostatix's Grant: